BioAtla, Inc. (BCAB)
USD 0.3
(2.0%)
USD 0.3
(2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -104.01 Million | -90.42 Million | -62.21 Million | -36.33 Million | -9.64 Million | -35.31 Million |
| Net Income | -123.46 Million | -106.48 Million | -95.4 Million | -35.85 Million | -29.85 Million | -28.97 Million |
| Depreciation & Amortization | 1.22 Million | 1.19 Million | 1.33 Million | 1 Million | 860 Thousand | 794 Thousand |
| Deferred income taxes | -5.28 Million | - | -686 Thousand | 4.46 Million | 6403.00 | - |
| Stock-based compensation | 13.54 Million | 14.56 Million | 25.11 Million | 3.02 Million | -6403.00 | 2637.00 |
| Change in working capital | 4.68 Million | 287 Thousand | 7.42 Million | -2.49 Million | 25.1 Million | -9.7 Million |
| Other non-cash items | 5.28 Million | 13 Thousand | 3000.00 | -6.47 Million | -5.75 Million | 2.57 Million |
| Investing Cash Flow | -98 Thousand | -265 Thousand | -924 Thousand | -590 Thousand | -1.5 Million | -988 Thousand |
| Investments in PPE | -98 Thousand | -268 Thousand | -924 Thousand | -590 Thousand | -1.5 Million | -988 Thousand |
| Acquisitions | - | 3000.00 | - | -19 Thousand | -5000.00 | 19 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 3.00 | -924 Thousand | 19 Thousand | 5000.00 | - |
| Financing Cash Flow | 77.00 | 61.21 Thousand | 69.51 Million | 271.82 Million | 3.99 Million | 5.01 Million |
| Debt repayment | - | - | - | -3.43 Million | -4 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -259.00 | -758.00 | - | - | - | - |
| Common Stock Issuance | 336 Thousand | 61.97 Million | 71.42 Million | 200.22 Million | - | - |
| Other Financing Activities | 336.00 | 61.97 Thousand | -1.91 Million | 75.02 Million | 7.99 Million | 5.01 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 5.28 Million | 3.41 | 7.99 Million | -1.66 Million | 3.13 Million | 446 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -604 Thousand | 286.99 Thousand | -568 Thousand | -838 Thousand | 21.97 Million | -10.15 Million |
| Cash at beginning of period | 215.5 Million | 244.97 Million | 238.6 Million | 3.7 Million | 10.86 Million | 42.14 Million |
| Cash at end of period | 111.47 Million | 215.5 Million | 244.97 Million | 238.6 Million | 3.7 Million | 10.86 Million |
| Capital Expenditure | -98 Thousand | -268 Thousand | -924 Thousand | -590 Thousand | -1.5 Million | -988 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -104.03 Million | -29.47 Million | 6.37 Million | 234.9 Million | -7.15 Million | -31.28 Million |
| Free Cash Flow | -104.11 Million | -90.68 Million | -63.13 Million | -36.92 Million | -11.15 Million | -36.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.07 Million | -23.23 Million | -123.46 Million | -26.92 Million | -33.32 Million | -35.75 Million |
| Depreciation & Amortization | 229 Thousand | 240 Thousand | 1.22 Million | 368 Thousand | 270 Thousand | 290 Thousand |
| Deferred income taxes | - | - | -5.28 Million | -10.72 Million | -29.8 Million | -32.07 Million |
| Stock-based compensation | 2.49 Million | 2.3 Million | 13.54 Million | 2.73 Million | 3.51 Million | 3.67 Million |
| Change in working capital | -846 Thousand | -10.13 Million | 4.68 Million | -6.1 Million | 2.19 Million | 7.69 Million |
| Other non-cash items | 4.9 Million | 11.75 Million | 5.28 Million | 10.72 Million | 29.8 Million | 32.07 Million |
| Investing Cash Flow | - | - | -98 Thousand | -8000.00 | -25 Thousand | -15 Thousand |
| Investments in PPE | - | - | -98 Thousand | -8000.00 | -25 Thousand | -15 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 225 Thousand | -13 Thousand | 77.00 | 119.00 | -41.00 | 115.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 244 Thousand | -13.00 | -259.00 | -30.00 | -55.00 | -58.00 |
| Common Stock Issuance | 244 Thousand | - | 336 Thousand | 149 Thousand | 14 Thousand | 173 Thousand |
| Other Financing Activities | -19 Thousand | -13 Thousand | 336.00 | 149.00 | 14.00 | 173.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.94 Million | -8.97 Million | 5.28 Million | -7.24 Million | 1.95 Million | 7.42 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.1 Million | -1.15 Million | -604 Thousand | 1.14 Million | 235 Thousand | 269 Thousand |
| Cash at beginning of period | 80.63 Million | 111.47 Million | 215.5 Million | 141.28 Million | 168.69 Million | 192.68 Million |
| Cash at end of period | 61.66 Million | 80.63 Million | 111.47 Million | 111.47 Million | 141.28 Million | 168.69 Million |
| Capital Expenditure | - | - | -98 Thousand | -8000.00 | -25 Thousand | -15 Thousand |
| Effect of forex changes on cash | - | - | - | 10.21 Million | -2.35 Million | -7.85 Million |
| Net cash flow / Change in cash | -18.96 Million | -30.84 Million | -104.03 Million | -29.81 Million | -27.41 Million | -23.99 Million |
| Free Cash Flow | -19.19 Million | -30.82 Million | -104.11 Million | -29.93 Million | -27.37 Million | -24.1 Million |
ORS
AAFRF
IBTX
RCK
MXCT
2327